New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 2, 2012
16:57 EDTFLEX, ALIMAlimera Sciences, Flextronics enter manufacturing services agreement
Alimera Sciences (ALIM) entered into a Manufacturing Services Agreement with Flextronics Medical Sales and Marketing. Under the Agreement, Flextronics (FLEX) will manufacture Alimera’s proprietary inserter system for use with ILUVIEN, Alimera’s sustained release intravitreal implant for the treatment of chronic diabetic macular edema. Under the Agreement, Alimera will pay certain per Product unit prices based on regularly scheduled shipments of a minimum number of Product units.
News For ALIM;FLEX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 24, 2015
09:06 EDTFLEXFlextronics officially changes name to 'Flex'
Flextronics announced that it has officially changed its name to Flex. "We have progressed in our product and service offering over the years, adding many new solutions, and today we are much more than just an EMS, supply chain solutions or 'tronics' company. Our new website and corporate identity better reflect who we are. We are proud to be our customers' sketch-to-scale competitive advantage, further enabling a simpler, richer life through technology," said Michael Mendenhall, Flex chief marketing and communications officer.
July 23, 2015
16:22 EDTFLEXFlextronics sees Q2 adjusted EPS 22c-28c, consensus 25c
Sees Q2 revenue $5.9B-$6.5B, consensus $6.23B.
16:21 EDTFLEXFlextronics reports Q1 adjusted EPS 23c, consensus 23c
Reports Q1 revenue $5.57B, consensus $5.89B.
July 21, 2015
13:42 EDTFLEXElectronic manufactures higher after Sanmina Q3 results
Subscribe for More Information
07:37 EDTALIMAlimera Sciences signs exclusive agreement for distribution of Iluvien in Canada
Alimera Sciences announced that it has signed an exclusive agreement with Knight Therapeutics, a leading Canadian specialty pharmaceutical company, for the distribution in Canada of ILUVIEN, Alimera's sustained release intravitreal implant for the treatment of diabetic macular edema. Under the terms of this agreement, Knight will also handle all regulatory and commercial activities for ILUVIEN in Canada. ILUVIEN currently is not approved for sale in Canada.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use